# Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis

> **NCT04670653** · PHASE3 · WITHDRAWN · sponsor: **EMS**

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** MAGNÓLIA NASAL GEL
- **DRUG:** MOMETASONE FUROATE

## Key facts

- **NCT ID:** NCT04670653
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-07
- **Final completion:** 2023-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04670653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04670653, "Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04670653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*